Breakthrough Designation for ORTHOSON’s Bio-Structural Gel

ORTHOSON’s Bio-Structural Gel was granted Breakthrough Device Designation by FDA. This micro-invasive treatment is designed to alleviate back pain due to degenerative disc disease.

ORTHOSON’s Bio-Structural Gel follows the natural fissures of degeneration in the nucleus pulposus of the intervertebral disc, before gelling in situ to form a...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us